Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 2, 2009, 7:19PM ET - U.S. Markets Closed. Dow  0.18% Nasdaq  0.42%

Sangamo Biosciences Inc. (SGMO)

At 4:00PM ET: 5.69   0.21 (3.83%)

MORE ON SGMO

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Nov 18, 2009 • Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS PR Newswire (Wed, Nov 18) Fri, Nov 6, 2009 • SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Nov 6) Thu, Nov 5, 2009 • Sangamo 3Q loss narrows on payments, lower costs AP (Thu, Nov 5) • New Star Analyst Rankings for Sangamo BioSciences, Inc. StarMine (Thu, Nov 5) Wed, Nov 4, 2009 • Sangamo Biosciences, Inc. Q3 2009 Earnings Call Transcript at Seeking Alpha (Wed, Nov 4) • SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online (Wed, Nov 4) • Sangamo BioSciences Reports Third Quarter 2009 Financial Results PR Newswire (Wed, Nov 4) • Q3 2009 Sangamo BioSciences Earnings Release - After Market Close CCBN (Wed, Nov 4) Tue, Nov 3, 2009 • Sangamo BioSciences Announces Presentation at Merriman Curhan Ford's Investor Summit 2009 PR Newswire (Tue, Nov 3) Fri, Oct 30, 2009 • 4-Star Stocks on the Upswing at Motley Fool (Fri, Oct 30) Wed, Oct 28, 2009 • Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast PR Newswire (Wed, Oct 28) • Sangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Finger Nuclease-Based Stem Cell Therapy for HIV/AIDS PR Newswire (Wed, Oct 28) Fri, Oct 23, 2009 • Sigma-Aldrich profit up, sales drop slightly at bizjournals.com (Fri, Oct 23) Thu, Oct 22, 2009 • Sigma-Aldrich profit up, sales drop slightly at bizjournals.com (Thu, Oct 22) Tue, Oct 20, 2009 • Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting PR Newswire (Tue, Oct 20) Mon, Oct 19, 2009 • Coverage initiated on Sangamo BioSci by Brean Murray Briefing.com (Mon, Oct 19) Fri, Oct 16, 2009 • StockPreacher.com Issues Trading Outlook for GenVec Inc. GlobeNewswire (Fri, Oct 16) Thu, Oct 15, 2009 • Zacks Bull and Bear of the Day Highlights: Sangamo Biosciences, Inc., Conmed, Intel Corp., JPMorgan Chase & Company and CSX Corp. Zacks.com (Thu, Oct 15) • Sangamo Biosciences (SGMO) Zacks.com (Thu, Oct 15) Tue, Oct 13, 2009 • Sangamo closes stock sale, raising $20.9M AP (Tue, Oct 13) Older Headlines - Download Recent Headlines View headlines from: Tue, Oct 13, 2009Tue, Oct 6, 2009Tue, Sep 29, 2009Tue, Sep 22, 2009Tue, Sep 15, 2009Tue, Sep 8, 2009Tue, Sep 1, 2009Tue, Aug 25, 2009Tue, Aug 18, 2009Tue, Aug 11, 2009 Add SGMO News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage